Fig 6From: Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1)Increased cleaved caspase 3 staining by [177Lu]Lu-DOTA-Miltuximab®. a Representative IHC images of H&E, Ki-67 and cleaved caspase 3 staining from mouse tumour samples. b Quantitation of Ki-67 and cleaved caspase 3 positive stains. Data are expressed as % of total tissue. Shown are mean ± SEM. Statistical analysis using unpaired t test. *p < 0.05Back to article page